Ultra-processed food – a threat to liver health
Ultra-spracované potraviny – hrozba pre zdravie pečene
Ultra-spracované potraviny (UPF) sa často vyznačujú nízkou nutričnou kvalitou, vysokou energetickou hustotou a prítomnosťou prídavných látok, látok z obalov a zlúčenín, ktoré vznikajú počas výroby, spracovania a skladovania. UPF zahŕňa priemyselné receptúry a zvyčajne obsahuje mnoho zložiek. UPF obsahuje cukor, oleje, tuky, soľ, antioxidanty, stabilizátory a konzervačné látky, potravinárske prísady a emulgátory. Okrem nízkej výživovej hodnoty spracovanie potravín podporuje tvorbu škodlivých zlúčenín v potravinách. Potravinové prísady v rámci UPF, podporujú zápaly, poruchy funkcie pečene a metabolický syndróm, ktoré sú založené na zmenách mikrobiómu. Obezogény sú látky z prostredia, ktoré menia rovnováhu medzi príjmom a výdajom energie. Obezogény sú podskupinou environmentálnych chemických látok, ktoré pôsobia ako endokrinné disruptory ovplyvňujúce koncové metabolické ukazovatele. V posledných desaťročiach sa na celom svete dramaticky zvýšila spotreba ultra-spracovaných výrobkov. UPF sa na priemernom energetickom príjme podieľali viac ako 60 %. Priemerný obsah bielkovín, vlákniny, vitamínov a vápnika v strave výrazne klesá. Energetický príspevok UPF, zatiaľ čo obsah sacharidov, pridaného cukru a nasýtených tukov sa zvyšuje. Ultra-spracované potraviny sa podieľajú na väčšine pridaných cukrov v západnej strave. Fruktóza – najčastejší obezogén, sa spája so zvýšeným rizikom fibrózy pečene. V posledných rokoch pribúdajú dôkazy o škodlivom vplyve UPF. Konzumácia UPF sa spája s metabolickými zmenami, výskytom chronických ochorení a nadmernou úmrtnosťou. Existujú aj dôkazy o súvislosti s NAFLD, NASH a fibrózou. Vysoká spotreba UPF súvisí so škodlivými metabolickými a hepatálnymi parametrami v populácii NAFLD. Okrem toho kombinácia fajčenia a vysokého príjmu UPF môže zosilniť poškodenie pečene. Na základe dôkazov zo štúdií by sa vo výživových usmerneniach malo zvážiť odporúčanie znížiť príjem ultra- -spracovaných potravín na minimum a implementovať opatrenia v oblasti verejného zdravotníctva.
Klíčová slova:
metabolický syndrom – nealkoholová tuková choroba pečene (NAFLD) – ultra-spracované potraviny (UPF) – obezogény – chemické látky narúšajúce endokrinný systém (EDC)
Authors:
M. Rác 1; M. Janičko 2; T. Koller 3; L. Skladaný 4
Authors place of work:
Department of Internal Medicine, Teaching Hospital Nitra
1; 2nd Department of Internal Medicine, P. J. Safarik University, Faculty of Medicine and L. Pasteur University Hospital Košice
2; 5th Department of Internal Medicine, University Hospital Bratislava, Comenius University, Faculty of Medicine, Bratislava
3; 2nd Department of Internal Medicine, HEGITO, F. D. Roosevelt University Hospital, Banská Bystrica
4
Published in the journal:
Gastroent Hepatol 2023; 77(2): 123-129
Category:
doi:
https://doi.org/10.48095/ccgh2023123
Summary
Ultra-processed foods (UPF) are often characterized by low nutritional quality, high energy density, and the presence of additives, substances from packaging, and compounds formed during production, processing, and storage. UPF includes industrial formulations, and usually contains many ingredients. UPF includes sugar, oils, fats, salt, antioxidants, stabilizers and preservatives, food additives, and emulsifiers. Beyond the poor nutritional value, food processing promotes the creation of harmful compounds in the food. Food additives within UPF, promote inflammation, liver dysfunction, and metabolic syndrome, which are based on changes in the microbiome. Obesogens are environmental substances that alter the balance between energy intake and energy expenditure. Obesogens are a subset of environmental chemicals that act as endocrine disruptors affecting metabolic endpoints. The consumption of ultra-processed products has increased dramatically worldwide in the last decades. UPF contributed more than 60% of the mean energy intake. The average content of protein, fiber, vitamins, and calcium in the diet decreases significantly. The roducy contribution of UPFs, while carbohydrate, added sugar, and saturated fat contents increase. Ultra-processed foods contribute most of the added sugars in the western diet. Fructose – the most frequent obesogen, is associated with an increased risk of liver fibrosis. In recent years, there has been growing evidence about the harmful effect of UPF. UPF consumption is associated with metabolic alterations, the incidence of chronic diseases, and excess mortality. There is also evidence for an association with NAFLD, NASH, and fibrosis. High UPF consumption is related to harmful metabolic and hepatic parameters in NAFLD population. Furthermore, the combination of smoking and high UPF intake may amplify liver damage. The evidence from studies, a recommendation to reduce ultra-processed food intake to a minimum should be considered in nutritional guidelines and implemented by public health policy measures.
Keywords:
metabolic syndrome – non-alcoholic fatty liver disease (NAFLD) – ultra-processed food (UPF) – obesogens – endocrine disrupting chemicals (EDCs)
Introduction
Food has a profound impact on health. The scientific connection between food and health has been well documented for many decades, with substantial and increasingly robust evidence showing that a healthy lifestyle, including a healthy dietary pattern, can help achieve and maintain good health and reduce the risk of chronic diseases throughout the lifespan. The core elements of a healthy dietary pattern are remarkably consistent across the lifespan and health outcomes. Food as one of the necessities of life can be defined as a repertoire of nutrients and substances essential for the growth, repair, and maintenance of body tissues and for the regulation of vital processes. Nutrients provide the energy that bodies need to function. A revolution in food science and the food industry over the last 60 years has led to explosive growth in the manufacturing and consumption of ultra-processed foods (UPFs). This shift began in high-income countries but has now reached countries at all income levels [1,2]. In the 60s of the 20th century, the association of cholesterol (Framingham study) and cardiovascular diseases was discovered, and therefore fats became enemies in nutrition for several decades [3]. UPF can be considered a starting point for covering the needs of the population. Increasing population density in developed countries and the increase of the concentration of population in large cities presents a logistical problem with the distribution and availability of fresh food. The rapid development of the food industry with an increase in the production of UPF can be considered a natural phenomenon associated with the development of civilization. UPF is a substantial factor affecting worldwide increases in the prevalence and incidence of obesity and other non-communicable diseases [4,5]. UPFs’ poor nutritional profiles, hyperpalatability (and, arguably, addictive nature), and content of biologically harmful compounds harm health status. The recommendation to prefer unprocessed/minimally processed foods and freshly made meals instead of ultra-processed foods are being increasingly adopted in the new official dietary guidelines issued by national governments and international health associations. This recommendation is supported by systematic reviews and meta-analyses of nationally representative dietary surveys and long-term cohort studies [6]. These data show that increased intake of UPF is associated with increased morbidity and mortality from several chronic diseases. Nevertheless, our modern eating patterns don’t reflect this recommendation. A recent survey revealed that 75% of people don’t eat enough vegetables, fruits and dairy [6]. Sixty-three percent exceed the limit for added sugars, and 77% exceed the limit for saturated fats. Not only the quantity but also the quality of the food contributes to heart disease, high blood pressure, type 2 diabetes, certain types of cancer or nonalcoholic steatohepatitis, and liver cirrhosis.
Definition of ultra-processed food
Ultra-processed consists of ready-to-consume formulations of industrially extracted ingredients and additives, typically created by series of industrial techniques and chemical processes. The consumption of ultra-processed food is linked to many diseases and is associated with several health negatives. Diets relying on highly processed foods comprise not only food-derived substances, along with additives, furthermore, are associated with exposure to industrialized preservatives and pesticides.
Processed food is defined by 7 food engineering criteria:
1. it is mass-produced,
2. is consistent batch to batch,
3. is consistent from country to country,
4. uses specialized ingredients from specialized companies,
5. consists of pre-frozen macronutrients,
6. stays emulsified, and
7. has long shelf life or freezer life [7].
Food processing generally refers to any action that alters food from its natural states, such as drying, freezing, milling, canning and adding salt, sugar, fat or other additives for flavor or preservation [8].
Furthermore, as professor Robert Lustig underscores in his work, there are additional nutritional properties that distinguish processed food [7]:
- Too little fiber. Fiber (soluble and insoluble) forms a gelatinous barrier along the intestinal wall. This delays the intestine’s ability to absorb nutrients, instead of feeding the gut microbiome. Physiological attenuation of the glucose rise results in beneficial insulin level reduction. Attenuation of fructose absorption reduces liver fat accumulation.
- Too few ω-3 and too many ω-6 fatty acids. ω-3s are precursors to docosahexaenoic and eicosapentaenoic acids (anti-inflammatory). Conversely, ω-6s are precursors of arachidonic acid (pro-inflammatory). The ratio of ω-6 to ω-3 fatty acids should be approximately 1: 1. Currently, this ratio is about 25: 1, favoring a pro-inflammatory state, which can drive oxidative stress and cell damage.
- Too few micronutrients. Antioxidants, such as vitamins C and E, quench oxygen radicals in peroxisomes to prevent cellular damage, while others, such as carotenoids and a-lipoic acid, prevent lipid peroxidation.
- Too many trans-fats. These fats cannot be oxidized by mitochondria owing to the trans-double bond, so they can damage arteries and the liver with the generation of reactive oxygen radicals.
- Too many branched-chain amino acids. Valine, leucine, and isoleucine are essential amino acids required for muscle biosynthesis. But when consumed in excess, they are deaminated in the liver and diverted to de novo lipogenesis, which increases liver fat.
- Too many emulsifiers. Emulsifiers prevent fat and water from separating. However, emulsifiers are detergents and may strip away the mucin layer that protects intestinal epithelial cells, predisposing individuals to leaky gut, intestinal disease, or food [9].
- Too many nitrates. Nitrates (cured meat) can be metabolized into nitrosoureas, which can predispose individuals to colon cancer.
- Too much salt. Approximately 15% of the population is salt sensitive and can manifest with hypertension and cardiac disease. Dietary salt may increase intestinal permeability and induce intestinal inflammation.
- Too much ethanol. Ethanol is converted into liver fat and drives oxidative stress.
Too much fructose. Fructose is metabolized by de novo lipogenesis in the liver. 74% of all the items in the grocery store contain added sugar; this makes sugar the basic marker for processed food [10].
The need to assess the quality of food was the basis for the creation of many existing classification systems. Researchers developed the NOVA classification system to categorize foods and beverages into one of four groups according to the extent and purpose of processing [11]:
- Group 1 (Unprocessed/minimally processed): Foods unaltered or altered by processes such as removing inedible parts, drying, grinding, cooking, pasteurization, freezing, or non-alcoholic fermentation. No substances are added. Processing aims to increase food stability and enable easier or more diverse preparation.
Unprocessed or minimally processed foods are whole foods in which the vitamins and nutrients are still intact. The food is in its natural (or nearly natural) state. These foods may be minimally altered by removal of inedible parts, drying, crushing, roasting, boiling, freezing, or pasteurization, to make them suitable to store and safe to consume. Unprocessed or minimally processed foods would include fruits and vegetables, and raw, unsalted nuts.
- Group 2 (Processed culinary ingredients): Substances obtained directly from Group 1 foods or from nature, created by industrial processes such as pressing, centrifuging, refining, extracting or mining. Processing aims to create products to be used in the preparation, seasoning, and cooking of Group 1 foods.
- Group 3 (Processed foods): Products made by adding edible substances from Group 2 to Group 1 foods using preservation methods such as non-alcoholic fermentation, canning or bottling. Processing aims to increase the stability and durability of Group 1 foods and to make them more enjoyable.
Group 4 (Ultra-processed foods): Formulations of low-cost substances derived from Group 1 foods with little to no whole foods; always contain edible substances not used in home kitchens (e. g. protein isolates) and/or cosmetic additives (e. g. flavors, colors, emulsifiers). Processing involves multiple steps and industries and aims to create products liable to replace all other NOVA groups [12].
When foods are highly processed or ultra-processed, they have many added ingredients (such as sugar, salt, fat, and artificial colors, or preservatives). Ultra-processed foods are made from substances extracted from foods, such as fats, starches, added sugars, and hydrogenated fats. They may also contain additives like artificial colors and flavors or stabilizers. Examples of these foods are frozen meals, soft drinks, hot dogs and cold cuts, fast food, packaged cookies, cakes and salty snacks.
UPFs are not simply foods that have been modified by processing, but rather edible products formulated from food-derived substances, along with additives that heighten their appeal and durability. UPFs are designed and manufactured for maximum profit: they contain low-cost ingredients, have long shelf lives, are hyper-palatable, and are highly branded and marketed to consumers. They are typically calorie-dense and high in free sugars, refined starches, unhealthy fats, and sodium. Today, UPFs are well recognized for their addictive qualities [13,14].
Changes in UPF consumption
UPFs have rapidly displaced unprocessed or minimally processed foods, freshly prepared meals, and traditional cooking in the diet in most countries, causing significant nutritional, social, economic, and environmental disruption and damage worldwide. UPFs – which did not exist before the mid-20th century now account for roughly half or more of the total calories consumed in the United States [15], and United Kingdom [16], with sales growing rapidly every year [1]. This worldwide shift towards greater consumption of UPFs coincided with global increases in obesity prevalence and other nutrition-related chronic diseases [17]. The detrimental health effects of UPFs tend to combine. UPF consumption worsens nutritional intake. UPFs are energy-dense and disproportionately contribute added sugars, sodium, unhealthy saturated and trans-fats, and highly refined carbohydrates to the diet while displacing consumption of less-processed and freshly prepared foods and their many beneficial nutrients [18,19]. UPFs inherently encourage overconsumption. For this issue of UPFs plays a role in convenience (i.e. products are typically ready-to-eat or ready-to-heat) [20,21]; hyper-palatability (formulations engineered to maximally please all the senses) [22]; disrupted satiety signaling [23,24]; and marketing that is highly pervasive and persuasive and often targeting children, as well as effective branding [25,26].
UPFs often contain harmful chemical substances. [27]. They include contaminants formed during high-temperature cooking [28].
Industrial additives linked to inflammation and gut dysbiosis (imbalances in the diversity and composition of gut microbiota) [29], and hormone-disrupting chemical compounds leached from plastics in food manufacturing and packaging materials [30–32].
Agrifood corporations are driving industrialization along the entire global food chain, from farm to plate. The driving force is profit. A key sector in agriculture is fertilizers and pesticide production and utilization. An analogous example is antibiotics use in large-scale meat production. Corporate-driven food systems have failed to deliver food security. That is because food systems severely harm both nature and the people on whom they depend.
UPF and obesogens
Obesogens are environmental chemicals that disrupt the action of receptors to promote adiposity or alter metabolism. Today, many thousands of chemicals are used in commerce. Chemical toxins have several modes of action. They can disrupt hormone levels or action. Their characteristics include the ability to interact with or activate hormone receptors, antagonize hormone receptors, alter hormone receptor expression, alter signal transduction in hormone-responsive cells, induce epigenetic modifications in hormone-producing or hormone-responsive cells, alter hormone synthesis, alter hormone transport across cell membranes, alter hormone distribution or circulating hormone levels.
Obesity is recognized as a multifactorial disease with both genetic and environmental components. The prevailing view is that obesity results from an imbalance between energy intake and expenditure caused by overeating and insufficient exercise. There is another important environmental element that can alter the balance between energy intake and energy expenditure: obesogens. Obesogens are a subset of environmental chemicals that act as endocrine disruptors affecting metabolic endpoints. The obesogen hypothesis posits that exposure to endocrine disruptors and other chemicals can alter the development and function of the adipose tissue, liver, pancreas, gastrointestinal tract, and brain, thus changing the set point for control of metabolism. Obesogens can determine how much food is needed to maintain homeostasis and thereby increase the susceptibility to obesity. Obesogens are chemicals that elicit increased white adipose tissue mass [33].
A variety of commonly prescribed drugs have adverse effects that result in weight gain (thiazolidinediones, tricyclic antidepressants, selective 5hydroxytryptamine uptake inhibitors and atypical antipsychotic drugs). Other chemical substances indicate that EDCs such as tributyltin, estrogenic chemicals such as bisphenol A, and chemicals acting via other mechanisms such as perfluorooctanoic acid, phthalates, polychlorinated biphenyls, some pesticides, dichlorodiphenyltrichloroethane (DDT). Polycyclic aromatic hydrocarbons (PAHs) are a family of environmental chemicals that are produced as byproducts of fuel burning. Benzopyrene as an example is a PAH that has been shown to inhibit lipolysis and cause increased fat accumulation [30].
Fructose cause changes in liver metabolism and energy signaling, creating a feedback loop in which insulin resistance and overeating occur. Fructose serves as a substrate for de novo lipogenesis and promotes hepatic insulin resistance, dyslipidemia and hepatic steatosis. Fructosylation of proteins with superoxide formation can result in hepatic inflammation-steatohepatitis. Fructose with its addictive properties and metabolic alterations in both hepatic metabolism and central nervous system energy signaling leads to excessive consumption and is consistent with metabolic syndrome development and its complications.
Health outcomes related to UPF consumption
A large and growing body of evidence has found strong associations between high UPF intake and health risks, including obesity, type 2 diabetes, depression, cardiovascular and cerebrovascular disease, mortality, cancer, chronic liver disease – especially NAFLD, and all-cause mortality [34–41].
Many systematic and narrative reviews have assessed the body of evidence for UPFs’ role in these and other health outcomes and they are consistent in their interpretation of the literature: high consumption of UPF is significantly associated with one or more adverse health outcomes in nearly every study to date [42].
Studies directly show that UPFs cause greater calorie intake and subsequent weight gain. High UPF intake was significantly associated with 23–51% greater odds of obesity and 39–49% greater odds of riskier abdominal obesity across three meta-analyses of observational studies comparing groups with highest vs. lowest UPF consumption. Added intake of UPF foods increases weight gain and the risk of overweight/obesity [4,5,35].
In studies comparing participants with the highest vs. lowest UPF consumption, the highest intake was significantly associated with a pooled:
- 29% greater relative risk of cardiovascular disease and/or mortality, and
- 34% greater relative risk of cerebrovascular disease and/or mortality [4].
High UPF intake was associated with a 22% greater risk of developing hypertension compared to low intake in a prospective study of 8,000 adults in Brazil [43]. Among children and adolescents, studies have found significant associations between high UPF intake and increases in total and LDL cholesterol from preschool to school age as well as increased cardiovascular disease risk into early adulthood [39,44].
Large prospective studies in the United Kingdom, France, and Spain have found 44–65% greater risk of developing type 2 diabetes among people in the highest vs. lowest groups of UPF consumption as well as a significant dose-response relationship, wherein every 10% increase in absolute UPF intake was associated with 12–15% greater risk of developing type 2 diabetes [36,37,45].
Studies examining UPF and depression found that participants in the highest quartile of UPF consumption had a 33% greater risk of developing depression relative to consumers in the lowest quartile and that for every 10% increase in UPF consumption, participants faced a 21% greater relative risk of depressive symptoms [38,46].
A 10% increase in the proportion of UPF in the diet was associated with an 11% increase in the risk of breast cancer and a 12% increase in the risk of overall cancer in a large prospective study [47].
In a study that followed roughly 1,300 Spanish older adults over 6 years, those in the highest third of UPF consumption had 74% greater odds of experiencing declining kidney function than those in the bottom third, independent of other chronic diseases or demographic, dietary, and lifestyle factors [48].
High UPF intake was associated with a tripled risk of frailty in older adults in a study comparing the highest and lowest quartiles intake among nearly 2,000 older adults in Spain over 3.5 years [49].
Pooled risk of all-cause mortality was 25–28% greater for the highest consumers of UPF relative to the lowest consumers across five prospective studies [40,50].
The risk of death was 50% higher from cardiovascular disease and 68% higher from heart disease for people in the highest vs. lowest quartiles of UPF intake in a large prospective cohort of over 90,000 participants. These mortality risks were higher for women than men [51].
UPF and IBD
Non-genetic external factors are important contributors to the pathogenesis of inflammatory bowel disease. There are several possible mechanisms through which UPF consumption may influence the development of IBD. UPF consumption may be associated with replacement of fiber. UPF contains additive substances that disrupt mucus-bacterial interaction in the gut. Emulsifying agents are chemically defined as detergent-like molecules. They are ubiquitous components of UPF and predispose to the development of inflammation. These components of UPF correlate with altered species composition and pro-inflammatory potential through mucus layer degradation and increased bacterial translocation [9]. Dietary salt and artificial sweeteners may increase intestinal permeability and induce intestinal inflammation through a reduction in fecal short-chain fatty acid production [52]. UPF intake was in studies associated with a higher risk of IBD. No significant heterogeneity was observed when the results for Crohn’s disease were compared with the results for ulcerative colitis. UPF is a proven environmental factor that increases the risk of IBD [53].
UPF and non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD)
Several studies have shown an association between UPFs and the risk of chronic diseases including; obesity, type 2 diabetes, cardiovascular disease, cancer, gastrointestinal disorders, frailty and mortality. Fructose consumption was demonstrated to be independently associated with NASH in children and adolescents, and fructose-containing beverages were also demonstrated to be associated with more severe fibrosis in NAFLD patients [54,55].
A recent study shows the association between the consumption of UPFs and NAFLD and related liver damage. Subjects with high UPF consumption had a higher prevalence of low HDL, hypertriglyceridemia, high TG/HDL ratio, hypertension, metabolic syndrome, higher serum ferritin levels, and a higher FibroTest score. They tended to consume more calories, with a higher proportion of calories from saturated fatty acids (SFA) and carbohydrates and a lower proportion from protein. Also, subjects with high UPF consumption tended to eat less fiber. Association of UPF consumption with NAFLD, presumed NASH and fibrosis. The prevalence of NASH, significant fibrosis, and elevated ferritin were associated with high consumption of UPFs [56]. The ideal diet for NAFLD should reduce fat mass and inflammation in the adipose tissue and liver parenchyma, restore insulin sensitivity and provide low amounts of substrates for de novo lipogenesis. Together with evidence from previous studies, a recommendation to reduce ultra-processed food intake to a minimum should be considered in nutritional guidelines and implemented by public health policy measures.
Conclusions
Consumption of UPFs has been undoubtedly linked with most non-communicable diseases. One of the links is with NAFLD/MAFLD. Combatting the tsunami of NAFLD which has afflicted all the regions of the world including Central Europe, is difficult to conceive without tackling the issue of UPS as one of the main therapeutic targets.
Submitted/Doručené: 6. 3. 2023
Accepted/Prijaté: 13. 3. 2023
Marek Rác, MD
Department of Internal Medicine
Teaching Hospital Nitra
Špitálska 6
949 01 Nitra
Gastroent Hepatol 2023; 77(2): 123– 129
Zdroje
1. Monteiro CA, Moubarac JC, Cannon G et al. Ultra-processed products are becoming dominant in the global food system. Obes Rev 2013; 14 (S2): 21–28. doi: 10.1111/obr.12107.
2. Popkin BM, Reardon T. Obesity and the food system transformation in Latin America. Obes Rev 2018; 19 (8): 1028–1064. doi: 10.1111/ obr.12694.
3. Dawber TR, Kannel WB. The Framingham Study An Epidemiological Approach to Coronary Heart Disease. Circulation 1966; 34 (4): 553–555. doi: 10.1161/01.CIR.34.4.553.
4. Pagliai G, Dinu M, Madarena MP et al. Consumption of ultra-processed foods and health status: A systematic review and meta-analysis. Br J Nutr 2021; 125 (3): 308–318. doi: 10.1017/ S0007114520002688.
5. Lane MM, Davis JA, Beattie S et al. Ultraprocessed food and chronic noncommunicable diseases: A systematic review and meta-analysis of 43 observational studies. Obes Rev 2021; 22 (3): 1–19. doi: 10.1111/obr.13146.
6. Phillips JA. Dietary Guidelines for Americans, 2020–2025. Work Heal Saf 2021; 69 (8): 395. doi: 10.1177/21650799211026980.
7. Lustig RH. Processed food-an experiment that failed. JAMA Pediatr 2017; 171 (3): 212–214. doi: 10.1001/jamapediatrics.2016.4136.
8. Jin J. Dietary guidelines for Americans. JAMA 2016; 315 (5): 528. doi: 10.1001/jama.2016. 0077.
9. Chassaing B, Koren O, Goodrich JK et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519 (7541): 92–96. doi: 10.1038/nature14232.
10. Lustig RH, Mulligan K, Noworolski SM et al. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity 2016; 24 (2): 453–460. doi: 10.1002/oby.21371.
11. Monteiro CA, Cannon G, Lawrence M et al. The NOVA Food Classification System and Its Four Food Groups. 2019 [online]. Dostupné z: https: //www.wipo.int/amc/en/mediation/rules.
12. Monteiro CA, Cannon G, Levy RB et al. Ultra-processed foods: What they are and how to identify them. Public Health Nutr 2019; 22 (5): 936–941. doi: 10.1017/S1368980018003762.
13. Schulte EM, Gearhardt AN. Attributes of the food addiction phenotype within overweight and obesity. Eat Weight Disord 2021; 26 (6): 2043–2049. doi: 10.1007/s40519-020-01055-7.
14. Garber AK, Lustig RH. Is Fast Food Addict- ive? Curr Drug Abuse Rev 2011; 4 (3): 146–162. doi: http: //dx.doi.org/10.2174/1874473711104030146.
15. Baraldi LG, Martinez Steele E, Canella DS et al. Consumption of ultra-processed foods and associated sociodemographic factors in the USA between 2007 and 2012: Evidence from a nationally representative cross-sectional study. BMJ Open 2018; 8 (3). doi: 10.1136/bmjopen- 2017-020574.
16. Rauber F, Louzada MLDC, Martinez Steele E et al. Ultra-processed foods and excessive free sugar intake in the UK: A nationally representative cross-sectional study. BMJ Open 2019; 9 (10): 1–11. doi: 10.1136/bmjopen-2018-027546.
17. Monteiro CA, Cannon G, Moubarac JC et al. The un Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing. Public Health Nutr 2018; 21 (1): 5–17. doi: 10.1017/S1368980017000234.
18. Luiten CM, Steenhuis IHM, Eyles H et al. Ultra-processed foods have the worst nutrient profile, yet they are the most available packaged products in a sample of New Zealand supermarkets. Public Health Nutr 2016; 19 (3): 530–538. doi: 10.1017/S1368980015002177.
19. Martínez Steele E, Popkin BM, Swinburn B et al. The share of ultra-processed foods and the overall nutritional quality of diets in the US: Evidence from a nationally representative cross-sectional study. Popul Health Metr 2017; 15 (1): 1–11. doi: 10.1186/s12963-017-0119-3.
20. Harris JM, Shiptsova R. Consumer Demand for Convenience Foods: Demographics and Expenditures. J Food Distrib Res 2007; 38 (3): 22–36.
21. Bellisle F. Meals and snacking, diet quality and energy balance. Physiol Behav 2014; 134: 38–43. doi: https: //doi.org/10.1016/j.physbeh. 2014.03.010.
22. Small DM, DiFeliceantonio AG. Neuroscience: Processed foods and food reward. Science 2019; 363 (6425): 346–347. doi: 10.1126/science.aav 0556.
23. Fardet A. Minimally processed foods are more satiating and less hyperglycemic than ultra-processed foods: A preliminary study with 98 ready-to-eat foods. Food Funct 2016; 7 (5): 2338–2346. doi: 10.1039/c6fo00107f.
24. Forde CG, Mars M, De Graaf K. Ultra-Processing or Oral Processing? A Role for Energy Density and Eating Rate in Moderating Energy Intake from Processed Foods. Curr Dev Nutr 2020; 4 (3): 1–7. doi: 10.1093/cdn/nzaa019.
25. Guimarães JS, Mais LA, Leite FHM et al. Ultra-processed food and beverage advertising on Brazilian television by International Network for Food and Obesity/Non-Communicable Diseases Research, Monitoring and Action Support benchmark. Public Health Nutr 2020; 23 (15): 2657–2662. doi: 10.1017/S1368980020000518.
26. Pulker CE, Scott JA, Pollard CM. Ultra-processed family foods in Australia: Nutrition claims, health claims and marketing techniques. Pub- lic Health Nutr 2018; 21 (1): 38–48. doi: 10.1017/ S1368980017001148.
27. Abt E, Robin LP, McGrath S, et al. Acrylamide levels and dietary exposure from foods in the United States, an update based on 2011–2015 data. Food Addit Contam – Part A Chem Anal Control Expo Risk Assess 2019; 36 (10): 1475–1490. doi: 10.1080/19440049.2019.1637548.
28. Gibis M. Heterocyclic Aromatic Amines in Cooked Meat Products: Causes, Formation, Occurrence, and Risk Assessment. Compr Rev Food Sci Food Saf 2016; 15 (2): 269–302. doi: 10.1111/1541-4337.12186.
29. Miclotte L, Van de Wiele T. Food processing, gut microbiota and the globesity problem. Crit Rev Food Sci Nutr 2020; 60 (11): 1769–1782. doi: 10.1080/10408398.2019.1596878.
30. Heindel JJ, Newbold R, Schug TT. Endocrine disruptors and obesity. Nat Rev Endocrinol 2015; 11 (11): 653–661. doi: 10.1038/nrendo.2015. 163.
31. Steele EM, Khandpur N, da Costa Louzada ML, Monteiro CA. Association between dietary contribution of ultra-processed foods and urinary concentrations of phthalates and bisphenol in a nationally representative sample of the US population aged 6 years and older. PLoS One 2020; 15: 1–21. doi: 10.1371/journal.pone.0236738.
32. Griffin MD, Pereira SR, DeBari MK et al. Mechanisms of action, chemical characteristics, and model systems of obesogens. BMC Biomed Eng 2020; 2 (1): 1–13. doi: 10.1186/s424 90-020-00040-6.
33. Heindel JJ, Howard S, Agay-Shay K et al. Obesity II: Establishing causal links between chemical exposures and obesity. Biochem Pharmacol 2022; 199: 115015. doi: 10.1016/j.bcp.2022.115015.
34. de Deus Mendonça R, Pimenta AM, Gea A et al. Ultraprocessed food consumption and risk of overweight and obesity: the University of Navarra Follow-Up (SUN) cohort study 1,2. Am J Clin Nutr 2016; 104 (5): 1433–1440. doi: 10.3945/ajcn.116.135004.
35. Beslay M, Srour B, Méjean C et al. Ultra-processed food intake in association with BMI change and risk of overweight and obesity: A prospective analysis of the French NutriNet-Santé cohort. PLoS Med 2020; 17 (8): 1–19. doi: 10.1371/JOURNAL.PMED.1003256.
36. Levy RB, Rauber F, Chang K et al. Ultra-processed food consumption and type 2 diabetes incidence: A prospective cohort study. Clin Nutr 2021; 40 (5): 3608–3614. doi: 10.1016/j.clnu.2020.12.018.
37. Llavero-Valero M, Escalada-San Martín J, Martínez-González MA et al. Ultra-processed foods and type-2 diabetes risk in the SUN project: A prospective cohort study. Clin Nutr 2021; 40 (5): 2817–2824. doi: 10.1016/j.clnu.2021.03. 039.
38. Adjibade M, Julia C, Allès B et al. Prospective association between ultra-processed food consumption and incident depressive symptoms in the French NutriNet-Santé cohort. BMC Med 2019; 17 (1): 78. doi: 10.1186/s12916-019-1312-y.
39. Juul F, Vaidean G, Lin Y et al. Ultra-Processed Foods and Incident Cardiovascular Disease in the Framingham Offspring Study. J Am Coll Cardiol 2021; 77 (12): 1520–1531. doi: 10.1016/j.jacc.2021.01.047.
40. Rico-Campà A, Martínez-González MA, Alvarez-Alvarez I et al. Association between consumption of ultra-processed foods and all cause mortality: SUN prospective cohort study. BMJ 2019; 365. doi: 10.1136/bmj.l1949.
41. Chang K, Gunter MJ, Rauber F et al. Articles Ultra-processed food consumption, cancer risk and cancer mortality : a large-scale prospective analysis within the UK Biobank. EClinicalMedicine 2023; 56: 101840. doi: 10. 1016/j.eclinm.2023.101840.
42. Elizabeth L, Machado P, Zinöcker M et al. Ultra-processed foods and health outcomes: A narrative review. Nutrients 2020; 12 (7): 1–36. doi: 10.3390/nu12071955.
43. Scaranni PO, Cardoso LO, Chor D et al. Ultra-processed foods, changes in blood pressure and incidence of hypertension: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Public Health Nutr 2021; 24 (11): 3352–3360. doi: 10.1017/S136898002100094X.
44. Rauber F, Campagnolo PDB, Hoffman DJ et al. Consumption of ultra-processed food products and its effects on children’s lipid profiles: A longitudinal study. Nutr Metab Cardiovasc Dis 2015; 25 (1): 116–122. doi: 10.1016/ j.numecd.2014.08.001.
45. Srour B, Fezeu LK, Kesse-Guyot E et al. Ultraprocessed Food Consumption and Risk of Type 2 Diabetes Among Participants of the NutriNet-Santé Prospective Cohort. JAMA Intern Med 2020; 180 (2): 283–291. doi: 10.1001/jama internmed.2019.5942.
46. Gómez-Donoso C, Sánchez-Villegas A, Martínez-González MA et al. Ultra-processed food consumption and the incidence of depression in a Mediterranean cohort: the SUN Project. Eur J Nutr 2020; 59 (3): 1093–1103. doi: 10.1007/s00394-019-01970-1.
47. Fiolet T, Srour B, Sellem L et al. Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort. BMJ 2018; 360: k322. doi: 10.1136/bmj.k322.
48. Rey-García J, Donat-Vargas C, Sandoval-Insausti H et al. Ultra-Processed Food Consumption is Associated with Renal Function Decline in Older Adults: A Prospective Cohort Study. Nutrients 2021; 13 (2): 428. doi: 10.3390/nu13020428.
49. Sandoval-Insausti H, Blanco-Rojo R, Graciani A et al. Ultra-processed Food Consumption and Incident Frailty: A Prospective Cohort Study of Older Adults. Journals Gerontol Ser A. 2020; 75 (6): 1126–1133. doi: 10.1093/gerona/glz140.
50. Schnabel L, Kesse-Guyot E, Allès B, et al. Association Between Ultraprocessed Food Consumption and Risk of Mortality Among Middle-aged Adults in France. JAMA Intern Med 2019; 179 (4): 490–498. doi: 10.1001/jamaintern med.2018.7289.
51. Zhong GC, Gu HT, Peng Y et al. Association of ultra-processed food consumption with cardiovascular mortality in the US population: long-term results from a large prospective multicenter study. Int J Behav Nutr Phys Act 2021; 18 (1): 21. doi: 10.1186/s12966-021-01081-3.
52. Rodriguez-Palacios A, Harding A, Menghini P et al. The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease-Like Ileitis. Inflamm Bowel Dis 2018; 24 (5): 1005–1020. doi: 10.1093/ibd/izy060.
53. Narula N, Wong ECL, Dehghan M et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: Prospective cohort study. BMJ 2021; 374. doi: 10.1136/bmj.n1554.
54. Mosca A, Nobili V, De Vito R et al. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. J Hepatol 2017; 66 (5): 1031–1036. doi: 10.1016/j.jhep.2016.12.025.
55. Abdelmalek MF, Suzuki A, Guy C et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51 (6): 1961–1971. doi: 10.1002/hep.23535.
56. Ivancovsky-Wajcman D, Fliss-Isakov N, Webb M et al. Ultra-processed food is asso- ciated with features of metabolic syndrome and non-alcoholic fatty liver disease. Liver Int 2021; 41 (11): 2635–2645. doi: https: //doi.org/10.11 11/liv.14996.
Štítky
Paediatric gastroenterology Gastroenterology and hepatology SurgeryČlánok vyšiel v časopise
Gastroenterology and Hepatology
2023 Číslo 2
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
- Obstacle Called Vasospasm: Which Solution Is Most Effective in Microsurgery and How to Pharmacologically Assist It?
Najčítanejšie v tomto čísle
- Autoimmune pancreatitis in childhood
- Ultra-processed food – a threat to liver health
- Neurobiology of liver diseases
- International experience with Crohn’s disease exclusion diet (CDED) with partial enteral nutrition (PEN)